Episode 405: Buprenorphine-naloxone for pharmaceutical opioid use disorder
Submitted by JPM on Fri, 2019-01-25 12:13.
In episode 405, Mike and James, with yet again the very smart and helpful Tina Korownyk, go over the evidence for buprenorphine-naloxone for pharmaceutical opioid use disorder. While the evidence is at moderate to high risk of bias the results are fairly impressive with NNTs of 3-5.
Show notes
Tools for Practice